Akụkọ
-
Tirzepatide maka mbelata ibu na ndị okenye buru ibu
Amara usoro ọgwụgwọ dabere na Incretin ogologo oge iji meziwanye ma njikwa glucose ọbara yana mbelata ibu ahụ. Ọgwụ incretin ọdịnala na-elekwasị anya na G...GỤKWUO -
Gịnị bụ ọrụ nke CJC-1295?
CJC-1295 bụ peptide sịntetik nke na-arụ ọrụ dị ka homonụ na-ewepụta homonụ (GHRH) analọg - nke pụtara na ọ na-akpali mwepụta anụ ahụ nke homonụ uto (GH ...GỤKWUO -
GLP-1–Ọgwụgwọ dabere maka mbelata ibu: Usoro, arụmọrụ, na ọganihu nyocha.
1. Mechanism of Action Glucagon-dị ka peptide-1 (GLP-1) bụ incretin hormone zoro ezo site na eriri afọ L-cell na nzaghachi na nri oriri. GLP-1 agonists nnabata (GLP-1 RAs) na-eṅomi phy hormone a ...GỤKWUO -
GHRP-6 Peptide – Hormone uto eke eke maka akwara na arụmọrụ
1. Nleba anya GHRP-6 ( Hormone na-ewepụta Peptide-6) bụ peptide sịntetịt nke na-akpali secretion eke nke hormone uto (GH). N'ịbụ nke e mepụtara iji gwọọ ụkọ GH, ọ ghọwo ...GỤKWUO -
Tirzepatide injection maka ọrịa shuga na mbelata ibu
Tirzepatide bụ akwụkwọ akụkọ abụọ na-adabere na insulinotropic polypeptide (GIP) na glucagon-dị ka peptide-1 (GLP-1) agonist nnabata. Usoro ya abụọ na-achọ ịkwalite mmepụta insulin, ...GỤKWUO -
Kedu ihe bụ PT-141?
Ngosipụta (iji akwadoro): Na 2019, FDA kwadoro ya maka ọgwụgwọ enwetara, nsogbu agụụ mmekọahụ zuru oke (HSDD) n'ime ụmụ nwanyị premenopausal mgbe ọnọdụ ahụ na-ebute akara d ...GỤKWUO -
Nkeji 2 Nnwale Clinical of Retatrutide, Hormone Triple-Receptor Agonist, maka ọgwụgwọ oke ibu.
Background and Study Design Retatrutide (LY3437943) bụ akwụkwọ akụkọ otu-peptide ọgwụ na-eme ka ndị nnata atọ rụọ ọrụ n'otu oge: GIP, GLP-1, na glucagon. Iji nyochaa nrụpụta ya na nchekwa ya na...GỤKWUO -
Kedu ihe bụ BPC-157
Aha zuru oke: Ngwakọta nchekwa nke ahụ-157, pentadecapeptide (15-amino acid peptide) nke dịpụrụ adịpụ na mmiri gastric mmadụ. Usoro Amino acid: Gly-Glu-Pro-Pro-Gly-Lys-Pro-Ala-Asp-As...GỤKWUO -
Ọgwụ dị elu nke semaglutide nwere ike imeziwanye oke ibu maka ndị okenye nwere oke ibu, nnwale ụlọ ọgwụ na-akwado.
Nnwale ụlọ ọgwụ ekwenyela na doses dị elu nke Semaglutide nwere ike na-enyere ndị okenye nwere oke ibu aka n'enweghị nsogbu ma nweta oke ibu. Nchọpụta a na-enye nkwado ọgwụgwọ ọhụrụ ...GỤKWUO -
Retatrutide, onye na-anabata ihe na-anabata homonụ ugboro atọ, maka ọgwụgwọ oke ibu - nnwale ụlọ ọgwụ nke ngalaba II.
N'ime afọ ndị na-adịbeghị anya, ọgwụgwọ oke ibu na ụdị ọrịa shuga 2 enweela ọganihu mgbanwe. Na-eso GLP-1 agonists nnabata (dịka, Semaglutide) na abụọ agonists (dịka, Tirzepatide), Reta...GỤKWUO -
Tirzepatide bụ agonist abụọ na-anabata ya
Okwu mmalite Tirzepatide, nke Eli Lilly mepụtara, bụ ọgwụ peptide ọhụrụ nke na-anọchi anya ihe dị ịrịba ama na ọgwụgwọ ụdị ọrịa shuga 2 na oke ibu. N'adịghị ka GLP-1 ọdịnala (glucagon-dị ka peptid ...GỤKWUO -
MOTS-c: Peptide Mitochondrial nwere uru ahụike na-ekwe nkwa
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) bụ obere peptide nke DNA mitochondrial debere nke dọtara mmasị sayensị dị ukwuu n'afọ ndị na-adịbeghị anya. Omenala, m...GỤKWUO